{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T19:03:49Z","timestamp":1775675029926,"version":"3.50.1"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA193675"],"award-info":[{"award-number":["R01 CA193675"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA222355"],"award-info":[{"award-number":["R01 CA222355"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R03 CA219731"],"award-info":[{"award-number":["R03 CA219731"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R03 CA230944"],"award-info":[{"award-number":["R03 CA230944"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Renal Cell Carcinoma (RCC) often becomes resistant to targeted therapies, and in addition, dose-dependent toxicities limit the effectiveness of therapeutic agents. Therefore, identifying novel drug delivery approaches to achieve optimal dosing of therapeutic agents can be beneficial in managing toxicities and to attain optimal therapeutic effects. Previously, we have demonstrated that Honokiol, a natural compound with potent anti-tumorigenic and anti-inflammatory effects, can induce cancer cell apoptosis and inhibit the growth of renal tumors<jats:italic>in vivo<\/jats:italic>. In cancer treatment, implant-based drug delivery systems can be used for gradual and sustained delivery of therapeutic agents like Honokiol to minimize systemic toxicity. Electrospun polymeric fibrous scaffolds are ideal candidates to be used as drug implants due to their favorable morphological properties such as high surface to volume ratio, flexibility and ease of fabrication. In this study, we fabricated Honokiol-loaded Poly(lactide-co-glycolide) (PLGA) electrospun scaffolds; and evaluated their structural characterization and biological activity. Proton nuclear magnetic resonance data proved the existence of Honokiol in the drug loaded polymeric scaffolds. The release kinetics showed that only 24% of the loaded Honokiol were released in 24hr, suggesting that sustained delivery of Honokiol is feasible. We calculated the cumulative concentration of the Honokiol released from the scaffold in 24hr; and the extent of renal cancer cell apoptosis induced with the released Honokiol is similar to an equivalent concentration of direct application of Honokiol. Also, Honokiol-loaded scaffolds placed directly in renal cell culture inhibited renal cancer cell proliferation and migration. Together, we demonstrate that Honokiol delivered through electrospun PLGA-based scaffolds is effective in inhibiting the growth of renal cancer cells; and our data necessitates further<jats:italic>in vivo<\/jats:italic>studies to explore the potential of sustained release of therapeutic agents-loaded electrospun scaffolds in the treatment of RCC and other cancer types.<\/jats:p>","DOI":"10.1371\/journal.pone.0243837","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T20:19:46Z","timestamp":1608236386000},"page":"e0243837","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Novel Honokiol-eluting PLGA-based scaffold effectively restricts the growth of renal cancer cells"],"prefix":"10.1371","volume":"15","author":[{"given":"Yasaman","family":"Hamedani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5232-0474","authenticated-orcid":true,"given":"Samik","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"Sabarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumitro","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sankha","family":"Bhowmick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5569-2273","authenticated-orcid":true,"given":"Murugabaskar","family":"Balan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,12,17]]},"reference":[{"issue":"4","key":"pone.0243837.ref001","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMra1601333","article-title":"Systemic Therapy for Metastatic Renal-Cell Carcinoma","volume":"376","author":"TK Choueiri","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0243837.ref002","first-page":"1016","article-title":"VEGF inhibitors in renal cell carcinoma","volume":"14","author":"P Vachhani","year":"2016","journal-title":"Clin Adv Hematol Oncol"},{"key":"pone.0243837.ref003","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.2147\/OTT.S97397","article-title":"Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection.","volume":"9","author":"SS Yu","year":"2016","journal-title":"Onco Targets Ther."},{"issue":"6","key":"pone.0243837.ref004","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.euo.2019.09.002","article-title":"First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.","volume":"2","author":"AW Hahn","year":"2019","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"pone.0243837.ref005","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1038\/s41598-017-05455-1","article-title":"Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth","volume":"7","author":"M Balan","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0243837.ref006","article-title":"A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape.","author":"A Sabarwal","journal-title":"Cancers (Basel)."},{"issue":"5","key":"pone.0243837.ref007","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1089\/ars.2009.2440","article-title":"Honokiol, a multifunctional antiangiogenic and antitumor agent.","volume":"11","author":"LE Fried","year":"2009","journal-title":"Antioxidants & redox signaling."},{"issue":"2","key":"pone.0243837.ref008","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.canlet.2013.05.036","article-title":"The natural product honokiol inhibits calcineurin inhibitor-induced and Ras-mediated tumor promoting pathways","volume":"338","author":"P Banerjee","year":"2013","journal-title":"Cancer Lett"},{"issue":"5","key":"pone.0243837.ref009","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/jcp.22954","article-title":"Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1","volume":"227","author":"P Rajendran","year":"2012","journal-title":"J Cell Physiol"},{"issue":"6","key":"pone.0243837.ref010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/CJI.0b013e3181a8efe6","article-title":"Honokiol-mediated inhibition of PI3K\/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function","volume":"32","author":"C Crane","year":"2009","journal-title":"J Immunother"},{"key":"pone.0243837.ref011","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijbiomac.2016.03.061","article-title":"Fabrication of porous gelatin-chitosan microcarriers and modeling of process parameters via the RSM method","volume":"88","author":"S.A M Karimian","year":"2016","journal-title":"International Journal of Biological Macromolecules"},{"key":"pone.0243837.ref012","first-page":"3","article-title":"Production and characterization of gelatine based electro-spun nanofibers as burn wound dressings.","volume":"14","author":"Y Hamedani","year":"2017"},{"issue":"4","key":"pone.0243837.ref013","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jbm.a.36861","article-title":"Electrospinning of tyrosine-based oligopeptides: Self-assembly or forced assembly","volume":"108","author":"Y Hamedani","year":"2020","journal-title":"Journal of Biomedical Materials Research Part A"},{"key":"pone.0243837.ref014","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.actbio.2018.09.024","article-title":"A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal\/chemo synergistic cancer therapy","volume":"80","author":"Y Guo","year":"2018","journal-title":"Acta Biomaterialia"},{"key":"pone.0243837.ref015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.micromeso.2017.01.036","article-title":"Multifunctional mesoporous silica nanoparticles for cancer-targeted, controlled drug delivery and imaging","volume":"242","author":"LBdO Freitas","year":"2017","journal-title":"Microporous and Mesoporous Materials"},{"key":"pone.0243837.ref016","doi-asserted-by":"crossref","first-page":"101905","DOI":"10.1016\/j.jddst.2020.101905","article-title":"Improved delivery and antimetastatic effects of Stattic by self-assembled amphiphilic pendant-dendron copolymer micelles in breast cancer cell lines","volume":"59","author":"YC Kwa","year":"2020","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"pone.0243837.ref017","doi-asserted-by":"crossref","first-page":"110830","DOI":"10.1016\/j.colsurfb.2020.110830","article-title":"Interface crosslinked mPEG-b-PAGE-b-PCL triblock copolymer micelles with high stability for anticancer drug delivery","volume":"189","author":"Y Lu","year":"2020","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"pone.0243837.ref018","first-page":"132","article-title":"Drug delivery systems for programmed and on-demand release","author":"P Davoodi","year":"2018","journal-title":"Advanced Drug Delivery Reviews"},{"key":"pone.0243837.ref019","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jconrel.2018.12.038","article-title":"Systems for stimuli-controlled release: Materials and applications","volume":"294","author":"M Bruneau","year":"2019","journal-title":"Journal of Controlled Release"},{"key":"pone.0243837.ref020","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.addr.2018.05.001","article-title":"Electrospinning: An enabling nanotechnology platform for drug delivery and regenerative medicine","volume":"132","author":"S Chen","year":"2018","journal-title":"Advanced Drug Delivery Reviews"},{"key":"pone.0243837.ref021","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2014.04.018","article-title":"Electrospinning of polymeric nanofibers for drug delivery applications. Journal of controlled release: official journal of the","volume":"185","author":"X Hu","year":"2014","journal-title":"Controlled Release Society"},{"issue":"18","key":"pone.0243837.ref022","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/09205063.2015.1100495","article-title":"Functionalization of electrospun poly(caprolactone) fibers for pH-controlled delivery of doxorubicin hydrochloride.","volume":"26","author":"M Jassal","year":"2015","journal-title":"Journal of Biomaterials Science, Polymer Edition"},{"issue":"11","key":"pone.0243837.ref023","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1016\/j.actbio.2010.05.025","article-title":"Fibrous scaffolds loaded with protein prepared by blend or coaxial electrospinning.","volume":"6","author":"W Ji","year":"2010","journal-title":"Acta Biomaterialia."},{"key":"pone.0243837.ref024","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.colsurfb.2012.10.016","article-title":"Electrospun polyvinyl-alcohol nanofibers as oral fast-dissolving delivery system of caffeine and riboflavin","volume":"103","author":"X Li","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"key":"pone.0243837.ref025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.actbio.2015.03.013","article-title":"Core\u2013shell designed scaffolds for drug delivery and tissue engineering","volume":"21","author":"RA Perez","year":"2015","journal-title":"Acta Biomaterialia"},{"key":"pone.0243837.ref026","first-page":"190","article-title":"Magnetic composite nanofibers fabricated by electrospinning of Fe3O4\/gelatin aqueous solutions","author":"S Wang","year":"2014","journal-title":"Materials Science and Engineering: B"},{"key":"pone.0243837.ref027","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2017.02.008","article-title":"Electrospun polyurethane nanofiber scaffolds with ciprofloxacin oligomer versus free ciprofloxacin: Effect on drug release and cell attachment","volume":"250","author":"MEE Wright","year":"2017","journal-title":"Journal of Controlled Release"},{"issue":"4","key":"pone.0243837.ref028","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1021\/ja211148a","article-title":"Superhydrophobic materials for tunable drug release: using displacement of air to control delivery rates","volume":"134","author":"ST Yohe","year":"2012","journal-title":"J Am Chem Soc"},{"key":"pone.0243837.ref029","first-page":"119618","article-title":"E-jet 3D printed drug delivery implants to inhibit growth and metastasis of orthotopic breast cancer","volume":"230","author":"Y Yang","journal-title":"Biomaterials. 2020"},{"issue":"4","key":"pone.0243837.ref030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0142-9612(81)90059-4","article-title":"Present and future applications of biomaterials in controlled drug delivery systems.","volume":"2","author":"R Langer","year":"1981","journal-title":"Biomaterials"},{"key":"pone.0243837.ref031","author":"AM Hillery","year":"2017","journal-title":"Drug delivery: fundamentals and applications2017"},{"key":"pone.0243837.ref032","article-title":"Biointerface engineering nanoplatforms for cancer-targeted drug delivery","author":"H Zhang","year":"2019","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"issue":"8","key":"pone.0243837.ref033","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1021\/acs.biomac.9b00528","article-title":"Glyconanoparticles for Targeted Tumor Therapy of Platinum Anticancer Drug.","volume":"20","author":"A Dag","year":"2019","journal-title":"Biomacromolecules"},{"key":"pone.0243837.ref034","volume-title":"Novel drug delivery systems","author":"YW Chien","year":"1992"},{"key":"pone.0243837.ref035","first-page":"553","volume-title":"Treatise on controlled drug delivery: fundamentals, optimization, applications.","author":"AF Kydonieus","year":"1992"},{"key":"pone.0243837.ref036","doi-asserted-by":"crossref","first-page":"111270","DOI":"10.1016\/j.colsurfb.2020.111270","article-title":"Active targeting liposome-PLGA composite for cisplatin delivery against cervical cancer","volume":"196","author":"P Dana","year":"2020","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"pone.0243837.ref037","doi-asserted-by":"crossref","first-page":"108336","DOI":"10.1016\/j.matdes.2019.108336","article-title":"3D printed biodegradable implants as an individualized drug delivery system for local chemotherapy of osteosarcoma.","volume":"186","author":"Y Wang","year":"2020","journal-title":"Materials & Design."},{"key":"pone.0243837.ref038","doi-asserted-by":"crossref","first-page":"100308","DOI":"10.1016\/j.mtchem.2020.100308","article-title":"Near infra-red light responsive carbon nanotubes@mesoporous silica for photothermia and drug delivery to cancer cells","volume":"17","author":"B Li","year":"2020","journal-title":"Materials Today Chemistry."},{"key":"pone.0243837.ref039","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jddst.2019.03.038","article-title":"Electrospun nanofibers for customized drug-delivery systems","volume":"51","author":"S Kajdi\u010d","year":"2019","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"pone.0243837.ref040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejpb.2017.01.022","article-title":"A minitablet formulation made from electrospun nanofibers","volume":"114","author":"B Poller","year":"2017","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"2","key":"pone.0243837.ref041","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijpharm.2017.05.017","article-title":"Application of miscibility analysis and determination of Soluplus solubility map for development of carvedilol-loaded nanofibers","volume":"533","author":"O Kaljevic","year":"2017","journal-title":"Int J Pharm"},{"key":"pone.0243837.ref042","first-page":"526","article-title":"Angelica gigas Nakai extract-loaded fast-dissolving nanofiber based on poly(vinyl alcohol) and Soluplus for oral cancer therapy.","author":"S Nam","year":"2017","journal-title":"International Journal of Pharmaceutics"},{"key":"pone.0243837.ref043","doi-asserted-by":"crossref","first-page":"789765","DOI":"10.1155\/2014\/789765","article-title":"Soluplus Graft Copolymer: Potential Novel Carrier Polymer in Electrospinning of Nanofibrous Drug Delivery Systems for Wound Therapy.","volume":"2014","author":"U Paaver","year":"2014","journal-title":"BioMed research international"},{"issue":"12","key":"pone.0243837.ref044","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1080\/09205063.2014.929431","article-title":"Electrospun DOXY-h loaded-poly(acrylic acid) nanofiber mats: in vitro drug release and antibacterial properties investigation.","volume":"25","author":"T Khampieng","year":"2014","journal-title":"Journal of Biomaterials Science, Polymer Edition"},{"issue":"7","key":"pone.0243837.ref045","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s11095-017-2155-x","article-title":"Cyclosporine A Loaded Electrospun Poly(D,L-Lactic Acid)\/Poly(Ethylene Glycol) Nanofibers: Drug Carriers Utilizable in Local Immunosuppression.","volume":"34","author":"J Sirc","year":"2017","journal-title":"Pharmaceutical research"},{"issue":"1\u20132","key":"pone.0243837.ref046","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ijpharm.2015.05.077","article-title":"Electrospun medicated shellac nanofibers for colon-targeted drug delivery","volume":"490","author":"X Wang","year":"2015","journal-title":"Int J Pharm"},{"issue":"4","key":"pone.0243837.ref047","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/jbm.a.36303","article-title":"Electrospun nanofibers comprising of silk fibroin\/gelatin for drug delivery applications: Thyme essential oil and doxycycline monohydrate release study","volume":"106","author":"M Dadras Chomachayi","year":"2018","journal-title":"J Biomed Mater Res A"},{"issue":"3","key":"pone.0243837.ref048","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0022-3549(15)00191-4","article-title":"Electrospun Poly(N-isopropylacrylamide)\/Ethyl Cellulose Nanofibers as Thermoresponsive Drug Delivery Systems.","volume":"105","author":"J Hu","year":"2016","journal-title":"Journal of pharmaceutical sciences"},{"key":"pone.0243837.ref049","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.msec.2017.08.007","article-title":"Electrospun gelatin\/sodium bicarbonate and poly(lactide-co-\u03b5-caprolactone)\/sodium bicarbonate nanofibers as drug delivery systems.","volume":"81","author":"Q Sang","year":"2017","journal-title":"Materials Science and Engineering: C"},{"issue":"46","key":"pone.0243837.ref050","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1002\/adfm.201300746","article-title":"A Smart Hyperthermia Nanofiber with Switchable Drug Release for Inducing Cancer Apoptosis","volume":"23","author":"Y-J Kim","year":"2013","journal-title":"Advanced Functional Materials"},{"issue":"10","key":"pone.0243837.ref051","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.eurpolymj.2011.07.024","article-title":"Electro-responsive transdermal drug delivery behavior of PVA\/PAA\/MWCNT nanofibers","volume":"47","author":"J Yun","year":"2011","journal-title":"European Polymer Journal"},{"issue":"1","key":"pone.0243837.ref052","first-page":"85","article-title":"Indomethacin electrospun nanofibers for colonic drug delivery: preparation and characterization.","volume":"3","author":"A Akhgari","year":"2013","journal-title":"Adv Pharm Bull"},{"key":"pone.0243837.ref053","article-title":"Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors","author":"J Graham","year":"2019","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"pone.0243837.ref054","doi-asserted-by":"crossref","first-page":"237","DOI":"10.20892\/j.issn.2095-3941.2019.0169","article-title":"The role of a drug-loaded poly (lactic co-glycolic acid) (PLGA) copolymer stent in the treatment of ovarian cancer.","volume":"17","author":"Y Wang","journal-title":"Cancer Biol Med. 2020"},{"issue":"1\u20132","key":"pone.0243837.ref055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40204-017-0063-0","article-title":"Poly(lactic-co-glycolic) acid drug delivery systems through transdermal pathway: an overview.","volume":"6","author":"L Naves","year":"2017","journal-title":"Prog Biomater"},{"key":"pone.0243837.ref056","first-page":"525832","article-title":"Current Uses of Poly(lactic-co-glycolic acid) in the Dental Field: A Comprehensive Review.","volume":"2015","author":"MJR Virlan","year":"2015","journal-title":"Journal of Chemistry"},{"issue":"2","key":"pone.0243837.ref057","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bioactmat.2016.11.001","article-title":"Bioactive polymeric scaffolds for tissue engineering","volume":"1","author":"S Stratton","year":"2016","journal-title":"Bioactive Materials"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:50:21Z","timestamp":1670313021000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243837"}},"subtitle":[],"editor":[{"given":"Kalpana","family":"Ghoshal","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,17]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0243837","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,17]]}}}